<DOC>
	<DOCNO>NCT01349764</DOCNO>
	<brief_summary>When Vitamin D replacement initiate patient history urolithiasis , high incidence hypercalciuria careful follow-up patient , hypercalciuria could appropriately manage thiazide diuretic risk newly diagnose renal stone equivalent control group without Vitamin D replacements.the purpose study determine effect vitamin D replacement patient previous history urolithiasis present tertiary stone clinic term change 24-hour urine collection parameter evaluate lithogenic effect vitamin D replacement term development urolithiasis . Eighty-six eligible patient include term suboptimal vitamin D history calcareous urolithiasis urinary calcium excretion &lt; 7.5 mmol/day . Patients randomly divide 2 equal group depend whether receive vitamin D replacement follow-up 3 , 6 , 12 , &amp; 24 month .</brief_summary>
	<brief_title>Effect Vitamin D Replacement Patients With Urolithiasis</brief_title>
	<detailed_description>During last year , clinical study vitamin D confirm presence world-wide incidence vitamin D deficiency . Recently , investigator detect incidence 80 % vitamin D deficiency/ insufficiency patient present tertiary stone clinic . However , data literature regard safety vitamin D replacement highly specialized group patient . Consequently , clinician concerned vitamin D replacement patient fear increase risk hypercalciuria stone formation . This study aim determine effect vitamin D replacement patient present tertiary stone clinic term change 24-hour urine collection parameter secondary stone formation . Eighty- six eligible patient 25- ( OH ) D deficiency insufficiency ( defined serum level &lt; 72 nmol/L ) history calcareous urolithiasis urinary calcium excretion &lt; 7.5 mmol/day include study . Eligible patient randomly divide 2 equal group depend whether receive vitamin D replacement . Randomization do use computer-based random number generator . Patients receive vitamin D3 tablets 10.000 IU twice week 8 week follow maintenance dose 1.000 IU daily 21 month . All patient subject full history take clinical examination , urinalysis culture indicate , liver function test , urea creatinine , ionize normalized calcium , phosphate , magnesium , uric acid , potassium , PTH , TSH form vitamin D [ 25 ( OH ) D 1 , 25 ( OH ) 2D ] , low dose CT scan confirm stone free status baseline bone density scan , together metabolic stone workup consist stone analysis two 24-hour urine collection calculation volume , osmolality , pH , creatinine , urea , calcium , phosphate , chloride , magnesium , sodium , potassium , oxalate , citrate , uric acid , quantitative cystine . Similar follow-up measure do 3 , 6 , 12 , 18 &amp; 24 month . At end study , low dose CT scan bone density scan repeat . Data collect tabulated use commercially available SPSS software version 17 ( SPSSInc , Chicago , IL , USA ) . Descriptive statistic present term percentage , frequency , mean standard deviation parametric variable median interquartile range non-parametric . Differences group compare Fisher 's exact test categorical data Student 's t- test continuous variable . In addition , interplay 2 variable analyse use multivariate logistic-regression . The effect season recruitment change serum 25 ( OH ) D evaluate use multivariate analysis covariance ( ANCOVA ) two-tailed p-values less value 0.05 represent statistical significance . Time hypercalciuria time stone formation c analyse use survival analysis technique comparison 2 group use log-rank test .</detailed_description>
	<mesh_term>Urolithiasis</mesh_term>
	<mesh_term>Vitamins</mesh_term>
	<mesh_term>Vitamin D</mesh_term>
	<mesh_term>Ergocalciferols</mesh_term>
	<mesh_term>Cholecalciferol</mesh_term>
	<criteria>25OHD deficiency insufficiency ( defined serum level &lt; 75 nmol/L ) . History urolithiasis ( Calcareous stone ) . 24hour urinary calcium excretion &lt; 7.5 mmol/day ( normocalciuric ) . Low fracture risk ( estimate FRAX® , develop WHO ) . Age &lt; 18 year Renal dysfunction ( Serum creatinine concentration &gt; 150 μmol/L ) . History noncalcareous stone e.g . uric acid , cystine , struvite stone . Hypercalcemia ( serum ionize normalized calcium &gt; 1.32 mmol/L ) Patients secondary hypercalciuria e.g . primary hyperparathyroidism , sarcoidosis , hyperthyroidism , active malignancy . Evidence osteoporosis intermediate/high fracture risk ( estimate FRAX ) . Patients take drug could potentially affect urinary calcium excretion ( vitamin D , calcium supplement , loop diuretic , steroid , lithium ) . Evidence liver dysfunction disorder may cause nonnutritional vitamin D deficiency abnormal bone development . Pregnancy lactation .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2016</verification_date>
	<keyword>vitamin D replacement</keyword>
	<keyword>Urolithiasis</keyword>
	<keyword>deficiency</keyword>
	<keyword>insufficiency</keyword>
</DOC>